β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial (vol 393, pg 1597, 2019)

被引：0
|
作者：
Villanueva, C.
Albillos, A.
Genesca, J.
机构：
来源：
LANCET | 2019年 / 393卷 / 10190期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2492 / 2492
页数：1
相关论文
共 50 条
  • [31] Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial
    Brusselle, Guy G.
    VanderStichele, Christine
    Jordens, Paul
    Deman, Rene
    Slabbynck, Hans
    Ringoet, Veerle
    Verleden, Geert
    Demedts, Ingel K.
    Verhamme, Katia
    Delporte, Anja
    Demeyere, Benedicte
    Claeys, Geert
    Boelens, Jerina
    Padalko, Elizaveta
    Verschakelen, Johny
    Van Maele, Georges
    Deschepper, Ellen
    Joos, Guy F. P.
    THORAX, 2013, 68 (04) : 322 - 329
  • [32] A multicentre, randomised, double-blind, placebo-controlled trial of aminophylline for bronchiolitis in infants admitted to intensive care
    Turner, Alastair
    Shann, Frank
    Delzoppo, Carmel
    Henning, Robert
    Slater, Anthony
    Beca, John
    Erickson, Simon
    Butt, Warwick
    CRITICAL CARE AND RESUSCITATION, 2014, 16 (03) : 220 - 224
  • [33] A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis
    Rinella, Mary E.
    Lieu, Hsiao D.
    Kowdley, Kris V.
    Goodman, Zachary D.
    Alkhouri, Naim
    Lawitz, Eric
    Ratziu, Vlad
    Abdelmalek, Manal F.
    Wong, Vincent Wai-Sun
    Younes, Ziad H.
    Sheikh, Aasim M.
    Brannan, Donald
    Freilich, Bradley
    Membreno, Fernando
    Sinclair, Marie
    Melchor-Khan, Liza
    Sanyal, Arun J.
    Ling, Lei
    Harrison, Stephen A.
    HEPATOLOGY, 2024, 79 (03) : 674 - 689
  • [34] Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
    Thwaites, Guy E.
    Scarborough, Matthew
    Szubert, Alexander
    Nsutebu, Emmanuel
    Tilley, Robert
    Greig, Julia
    Wyllie, Sarah A.
    Wilson, Peter
    Auckland, Cressida
    Cairns, Janet
    Ward, Denise
    Lal, Pankaj
    Guleri, Achyut
    Jenkins, Neil
    Sutton, Julian
    Wiselka, Martin
    Armando, Gonzalez-Ruiz
    Graham, Clive
    Chadwick, Paul R.
    Barlow, Gavin
    Gordon, N. Claire
    Young, Bernadette
    Meisner, Sarah
    McWhinney, Paul
    Price, David A.
    Harvey, David
    Nayar, Deepa
    Jeyaratnam, Dakshika
    Planche, Tim
    Minton, Jane
    Hudson, Fleur
    Hopkins, Susan
    Williams, John
    Torok, M. Estee
    Llewelyn, Martin J.
    Edgeworth, Jonathan D.
    Walker, A. Sarah
    LANCET, 2018, 391 (10121): : 668 - 678
  • [35] Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
    Sun, Fangfang
    Wang, Hui Jing
    Liu, Zhe
    Geng, Shikai
    Wang, Haiting
    Wang, Xiaodong
    Li, Ting
    Morel, Laurence
    Wan, Weiguo
    Lu, Liangjing
    Teng, Xiangyu
    Ye, Shuang
    LANCET RHEUMATOLOGY, 2020, 2 (04): : E210 - E216
  • [36] Efficacy of FPF 1070 (cerebrolysin) in patients with Alzheimer's disease - A multicentre, randomised, double-blind, placebo-controlled trial
    Xiao, SF
    Yan, HQ
    Yao, PF
    CLINICAL DRUG INVESTIGATION, 2000, 19 (01) : 43 - 53
  • [37] Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
    Allen, C.
    Counsell, C.
    Farrin, A.
    Al-Chalabi, A.
    Dickie, B.
    Leigh, P. N.
    Murphy, C. L.
    Payan, C.
    Reynolds, G.
    Shaw, P.
    Steen, I. N.
    Thornhill, M.
    Waters, J.
    Zajicek, J.
    Shaw, P. J.
    Young, C. A.
    Morrison, K. E.
    Dhariwal, S.
    Hornabrook, R.
    Savage, L.
    Burn, D. J.
    Khoo, T. K.
    Kelly, J.
    Dougherty, A.
    Wijesekera, L.
    Ellis, C. M.
    O'Hanlon, K.
    Panicker, J.
    Pate, L.
    Ray, P.
    Wyatt, L.
    Young, C. A.
    Copeland, L.
    Ealing, J.
    Hamdalla, H.
    Leroi, I.
    Murphy, C.
    O'Keeffe, F.
    Oughton, E.
    Partington, L.
    Paterson, P.
    Rog, D.
    Sathish, A.
    Sexton, D.
    Smith, J.
    Vanek, H.
    Dodds, S.
    Williams, T. L.
    Clarke, J.
    Eziefula, C.
    LANCET NEUROLOGY, 2013, 12 (04): : 339 - 345
  • [38] Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial
    Blum, Claudine Angela
    Nigro, Nicole
    Briel, Matthias
    Schuetz, Philipp
    Ullmer, Elke
    Suter-Widmer, Isabelle
    Winzeler, Bettina
    Bingisser, Roland
    Elsaesser, Hanno
    Drozdov, Daniel
    Arici, Birsen
    Urwyler, Sandrine Andrea
    Refardt, Julie
    Tarr, Philip
    Wirz, Sebastian
    Thomann, Robert
    Baumgartner, Christine
    Duplain, Herve
    Burki, Dieter
    Zimmerli, Werner
    Rodondi, Nicolas
    Mueller, Beat
    Christ-Crain, Mirjam
    LANCET, 2015, 385 (9977): : 1511 - 1518
  • [39] EFFECTS OF PIOGLITAZONE ON PORTAL AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH ADVANCED LIVER CIRRHOSIS: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    Ferlitsch, A.
    Pleiner, J.
    Homoncik, M.
    Reiberger, T.
    Schaller, G.
    Mittermayer, F.
    Wolzt, M.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S77 - S78
  • [40] EFFECTS OF PIOGLITAZONE ON PORTAL AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH ADVANCED LIVER CIRRHOSIS: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    Pleiner, J.
    Ferlitsch, A.
    Aschauer, S.
    Wolzt, M.
    Peck-Radosavljevic, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 123 - 123
12345